Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A simple quantitative in vitro macrophage migration assay

K K Bhopale1, K B Masani, K S Pradhan

  • 1Biology Department, Boots Pharmaceuticals Ltd, Sion, Bombay, India.

Indian Journal of Experimental Biology
|October 1, 1996
PubMed
Summary

This study describes an in vitro macrophage chemotaxis model. Concentrated chemoattractants, particularly from sodium caseinate, enhanced macrophage migration, offering a new tool for anti-inflammatory drug research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.

Die Pharmazie·2006
Same author

Quality control of anti-tuberculosis FDC formulations in the global market: part II-accelerated stability studies.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2005
Same author

Minimum sample size and sampling time requirements for assessment of rifampicin bioequivalence from FDC formulations.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2005
Same author

Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatment.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2005
Same author

Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.

Pharmacological research·2005
Same author

Plasma pooling: utility in expediting bioequivalence assessment of rifampicin-containing fixed-dose combinations.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2005

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Macrophage chemotaxis is crucial for immune responses.
  • Existing models for studying macrophage migration have limitations.

Purpose of the Study:

  • To establish a reliable in vitro model for macrophage chemotaxis.
  • To evaluate chemoattractant efficacy using non-specific elicitors.
  • To assess the impact of cell density and incubation conditions on chemotaxis.

Main Methods:

  • Developed an in vitro model using mouse peritoneal macrophages.
  • Prepared chemoattractants from oyster glycogen and sodium caseinate.
  • Utilized a modified Boyden chamber with a 48-well microchemotaxis assembly.
  • Investigated the effects of chemoattractant concentration, cell density, and incubation environments.

Related Experiment Videos

Main Results:

  • Maximal macrophage accumulation in vivo occurred at 48 hours post-injection.
  • Concentrated chemoattractant cocktails showed superior in vitro macrophage chemotaxis compared to diluted ones.
  • Optimal macrophage responsiveness was observed at a cell density of 4 x 10^6 cells/ml.
  • Sodium caseinate-derived chemoattractants demonstrated better efficacy than oyster glycogen.
  • Dimethyl Sulphoxide (DMSO) at 0.25% did not impede chemotaxis.

Conclusions:

  • The described in vitro system provides a robust model for studying macrophage chemotaxis.
  • This model can be used to screen and evaluate anti-inflammatory compounds directly impacting macrophage migration.